1999
DOI: 10.1046/j.1471-4159.1999.0720443.x
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Amyloid Precursor Protein Cleavage

Abstract: Multiple lines of evidence suggest that increased production and/or deposition of the ␤-amyloid peptide, derived from the amyloid precursor protein, contributes to Alzheimer's disease. A growing list of neurotransmitters, growth factors, cytokines, and hormones have been shown to regulate amyloid precursor protein processing. Although traditionally thought to be mediated by activation of protein kinase C, recent data have implicated other signaling mechanisms in the regulation of this process. Moreover, novel … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
182
1
2

Year Published

1999
1999
2013
2013

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 214 publications
(194 citation statements)
references
References 244 publications
(315 reference statements)
7
182
1
2
Order By: Relevance
“…This proteolytic cleavage constitutes the non-amyloidogenic pathway because it occurs within the b-amyloid (Ab) sequence, thereby preventing the formation of amyloidogenic fragments. The Ab peptide is formed and secreted as a physiological product of cell metabolism as a product of 'b-' and 'g-secretase' that cleave at the N and C termini of Ab respectively (reviewed by Mills and Reiner 6 and Racchi and Govoni 7 ). Both pathways are physiologically present in virtually all cell types and result in constitutive secretion of sAPPa and Ab.…”
Section: Introductionmentioning
confidence: 99%
“…This proteolytic cleavage constitutes the non-amyloidogenic pathway because it occurs within the b-amyloid (Ab) sequence, thereby preventing the formation of amyloidogenic fragments. The Ab peptide is formed and secreted as a physiological product of cell metabolism as a product of 'b-' and 'g-secretase' that cleave at the N and C termini of Ab respectively (reviewed by Mills and Reiner 6 and Racchi and Govoni 7 ). Both pathways are physiologically present in virtually all cell types and result in constitutive secretion of sAPPa and Ab.…”
Section: Introductionmentioning
confidence: 99%
“…Alzheimer's disease is a progressive neurodegenerative disorder characterized by the occurrence of senile plaques and neurofibrillary tangles throughout the brain cortex. The major component of the senile plaques is the amyloid β-peptide (Aβ), of M r $ 4 kDa, which is derived from the larger type I integral membrane APP, through sequential proteolytic cleavage by β-and γ-secretases [33,34]. APP can also be processed through a non-amyloidogenic pathway in which α-secretase cleaves the protein within the Aβ sequence, thereby precluding the formation of Aβ.…”
Section: Introductionmentioning
confidence: 99%
“…AD is characterized pathologically by the deposition of extracellular amyloid, containing the ␤-amyloid protein (A␤) (Glenner and Wong, 1984;Masters et al, 1985), which is derived from a 110 -130-kDa ␤-amyloid protein precursor (APP) (Kang et al, 1987). Cleavage of APP by ␤-and ␥-secretases results in the production of a peptide with 39 -43 amino acid residues (for review, see Mills and Reiner, 1999). Although A␤1-40 is the predominant form of A␤, the production of A␤1-42 may be linked more closely to disease pathogenesis (Suzuki et al, 1994;Mehta et al, 1998).…”
mentioning
confidence: 99%